Intercept Pharmaceuticals, Inc. (ICPT) NASDAQ

19.00

+0.04(+0.21%)

Updated at November 07, 2023 04:00PM

Currency In USD

Valuation

Market Cap418.37M
Enterprise Value700.53M
P/E Ratio5.58
PEG Ratio0.06
Price/Sales Ratio2.78
Price/Book Ratio6.9
Enterprise/Revenue3.77
Enterprise/EBITDA-17.45

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterSeptember 30, 2023

Profitability

Profit Margin0.4
Operating Margin-0.24

Management Effectiveness

Return On Assets0.21
Return On Equity-2.53

Income Statement

Revenue285.71M
Revenue/Share8.45
Gross Profit284.73M
EBITDA-61.7M
Net Income115.17M
Diluted EPS3.4

Balance Sheet

Total Cash322.71M
Total Cash/Share14.36
Total Debt223.86M
Total Debt/Equity3.57
Current Ratio2.35
Book Value Per Share2.75

Price History

52-Week Change35.81
52-Week High21.86
52-Week Low8.82
Moving Average 50 Days15.66
Moving Average 200 Days14.71

Statistics

Average Volume2.05M
Shares Outstanding41.83M
% Held by Institutions93.47

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A